MIPL-Logo

3decades

 

MIRA INFORM REPORT

 

 

Report No. :

509596

Report Date :

24.05.2018

 

 

 

IDENTIFICATION DETAILS

 

Name :

STANTECH PHARMACEUTICALS PRIVATE LIMITED

 

 

Registered Office :

B-518/519, Nand Dham, Opposite B.P. Mrine Institute, Sector - 11, Plot N.59, CBD Belapur, Navi Mumbai-400614

Mobile No.:

91-9819161722 [Mr. Ranjeet Desai]

 

 

Country :

India

 

 

Financials (as on) :

31.03.2017

 

 

Date of Incorporation :

26.05.2005

 

 

Com. Reg. No.:

11-153516

 

 

Capital Investment / Paid-up Capital :

INR 0.100 Million

 

 

CIN No.:

[Company Identification No.]

U24230MH2005PTC153516

 

 

IEC No.:

[Import-Export Code No.]

Not Divulged

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AAJCS0316B

 

 

GSTN :

[Goods & Service Tax Registration No.]

27AAJCS0316B1ZU

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturing and Trading of Pharmaceutical Products and Provides Consultancy Services. [Registered Activity]

 

 

No. of Employees :

Not Divulged

 

 

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January 2017)

 

MIRA’s Rating :

A

 

Credit Rating

Explanation

Rating Comments

A

Acceptable Risk

Business dealings permissible with moderate risk of default

 

Maximum Credit Limit :

USD 90500

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Slow but Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject was incorporated in the year 2005. The company is a manufacturer and trader of pharmaceutical products. It is also engaged in providing consultancy services.

 

As per the financial records of 2017, the company has reported a decline in its revenue as compared to the previous year’s revenue but has managed to maintain an average net profit margin of 1.46%.

 

The overall financial position of the company seems to be satisfactory marked by sufficient net worth base along with debt free balance sheet profile and comfortable liquidity parameter.

 

Rating takes into consideration the company’s favourable Earnings Per Share (EPS) of INR 174.76 as against its Face Value (FV) of INR 10.

 

Business is active. Payment seems to be slow but correct.

 

In view of aforesaid, the company can be considered for business dealings at usual trade terms and condition.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List

 

Country Name

Previous Rating

(30.09.2017)

Current Rating

(31.12.2017)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderately Low Risk

 

B1

Moderate Risk

 

B2

Moderately High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 

 

EXTERNAL AGENCY RATING

 

NOT AVAILABLE

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2018.

 

BIFR (Board for Industrial & Financial Reconstruction) LISTING STATUS

 

Subject’s name is not listed as a Sick Unit in the publicly available BIFR (Board for Industrial & Financial Reconstruction) list as of 24.05.2018

 

IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS

 

Subject’s name is not listed in the publicly available IBBI (Insolvency and Bankruptcy Board of India) list as of report date.

 

INFORMATION DECLINED BY

 

Name :

Mr. Ranjeet Desai

Designation :

Not Divulged

Contact No.:

91-9819161722

Date :

18.05.2018

 

LOCATIONS

 

Registered Office :

B-518/519, Nand Dham, Opposite B.P. Mrine Institute, Sector - 11, Plot N.59, CBD Belapur, Navi Mumba- 400614, India

Tel. No.:

91-22-67938584/ 8586/ 61878888/ 27565830

Mobile No.:

91-9819161722 [Mr. Ranjeet Desai]

Fax No.:

91-2227573391

E-Mail :

kailash@pharmaserv.in

roopa@stantechpharma.com

 

 

DIRECTORS

 

AS ON: 31.03.2017

 

Name :

Mr. Darshak Jitendra Shah

Designation :

Director

Address :

206/5608, Amey, R. N. Narkar Road, Ghatkopar (East), Mumbai-400075, Maharashtra, India

Date of Birth/Age :

13.01.1970

Date of Appointment :

03.11.2009

DIN No.:

00924587

Other Directorship :

CIN/FCRN

Company Name

Begin Date

U22100MH2009PLC197761

ADROIT BIOMED LIMITED

30/09/2017

U24230MH2004PTC146489

PHARMA SERV SOLUTIONS PRIVATE LIMITED

24/05/2004

U24233MH2007PTC171203

PHARMA SERV VENTURES PRIVATE LIMITED

29/05/2007

U74900MH2009PTC196131

LAVUE PHARMACEUTICALS PRIVATE LIMITED

21/12/2009

U74999MH2017PTC292897

NUTRAGENIX BIOLABS PRIVATE LIMITED

23/03/2017

U74999MH2017PTC292921

NUTRAGENIX HEALTHCARE PRIVATE LIMITED

23/03/2017

 

 

Name :

Mr. Murali Venkata Krishna Sistla

Designation :

Director

Address :

C-103, Oberoi Gardens, Thakur Village, Kandivali (East), Mumbai-400101, Maharashtra, India

Date of Appointment :

01.10.2012

DIN No.:

00925848

Other Directorship :

CIN/FCRN

Company Name

Begin Date

U24230MH2004PTC146489

PHARMA SERV SOLUTIONS PRIVATE LIMITED

24/05/2004

U24233MH2007PTC171203

PHARMA SERV VENTURES PRIVATE LIMITED

07/11/2008

U74900MH2009PTC196131

LAVUE PHARMACEUTICALS PRIVATE LIMITED

21/12/2009

U74999MH2017PTC292897

NUTRAGENIX BIOLABS PRIVATE LIMITED

23/03/2017

U74999MH2017PTC292921

NUTRAGENIX HEALTHCARE PRIVATE LIMITED

11/05/2017

 

 

Name :

Mr. Sameer Ashok Paigankar

Designation :

Director

Address :

Rh-4, 07,Sector-6 Vashi, Navi Mumbai-400703, Maharashtra, India

Date of Birth/Age :

11.09.1969

Date of Appointment :

26.05.2005

DIN No.:

01487210

Other Directorship :

CIN/FCRN

Company Name

Begin Date

U22100MH2009PLC197761

ADROIT BIOMED LIMITED

30/09/2017

U24230MH1995PTC091080

ZYDUS TRADING COMPANY PRIVATE LIMITED

16/05/2013

U24230MH2004PTC146489

PHARMA SERV SOLUTIONS PRIVATE LIMITED

24/05/2004

U24233MH2007PTC171203

PHARMA SERV VENTURES PRIVATE LIMITED

29/05/2007

U33100MH2003PTC139877

MY HEALTHSKAPE MEDICALS PRIVATE LIMITED

01/07/2005

U74120MH2013PTC240805

ACUMEDICA LAB SYSTEMS PRIVATE LIMITED

01/03/2013

U74900MH2009PTC196131

LAVUE PHARMACEUTICALS PRIVATE LIMITED

30/09/2009

U74999MH2016PTC283276

ACUMEDICA CONSULTING PRIVATE LIMITED

05/07/2016

U74999MH2017PTC292897

NUTRAGENIX BIOLABS PRIVATE LIMITED

23/03/2017

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON: 31.03.2017

 

Names of Shareholders

No. of Shares

Percentage of Holding

Sameer Ashok Paigankar

2000

20.00

Ashok Paigankar

1000

10.00

Darshak Jitendra Shah

5000

50.00

Sheela Sameer Paigankar

1000

10.00

Suneela Ashok Paigankar

1000

10.00

 

 

 

Total

10000

 

100.00

 

 

AS ON: 30.09.2017

 

Equity Share Breakup

Percentage of Holding

Category

 

Promoters – Individual/ Hindu Undivided Family – Indian

100.00

 

 

Total

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturing and Trading of Pharmaceutical Products and Provides Consultancy Services. [Registered Activity]

 

 

Products :

ITC Code No.

 

Product Descriptions

98041000

Sale of Drugs & Pharma products

99839390

Other scientific and technical consulting services n.e.c.

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Divulged

 

 

Imports :

Not Divulged

 

 

Terms :

 

Selling :

Not Divulged

 

 

Purchasing :

Not Divulged

 

PRODUCTION STATUS: NOT AVAILABLE

 

 

GENERAL INFORMATION

 

Suppliers :

Reference:

Not Divulged

Name of the Person (Designation):

--

Contact Number:

--

Since how long known:

--

Maximum limit dealt:

--

Experience:

--

Remark

--

 

 

Customers :

 

Reference:

Not Divulged

Name of the Person (Designation):

--

Contact Number:

--

Since how long known:

--

Maximum limit dealt:

--

Experience:

--

Remark

--

 

 

No. of Employees :

Not Divulged

 

 

Bankers :

 

Bank Name:

Not Divulged

Branch:

Not Divulged

Person Name (with Designation):

--

Contact Number:

--

Name of Account Holder:

--

Account Number:

--

Account Since (Date/ Year of A/c Opening):

--

Average Balance Maintained (Optional):

--

Credit Facilities Enjoyed (CC/OD/Term Loan):

--

Account Operation:

--

Remarks:

--

 

 

 

Auditors :

 

Name :

PHD and Assocites

Chartered Accountants

Address :

Radha Chambers, Level 3, Telli Park Lane, Andheri (East), Mumbai-400069, Maharashtra, India

Tel. No.:

91-22-26820083

Fax No.:

91-22-26830824

E-Mail :

phd@phd-ca.com

Website:

http://www.phd-ca.com

PAN No.:

AALFP4587E

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Enterprises over which the key managerial personnel have influence :

  • Pharma Serv Ventures Private Limited
  • Pharma Serv Solutions Private Limited
  • Lavue Pharmaceuticals Private Limited

             (Formerly known as Q-Rexa Pharmaceuticals Private Limited)

 


 

CAPITAL STRUCTURE

 

AS ON: 31.03.2017

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

100000

Equity Shares

INR 10/- each

INR 1.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

10000

Equity Shares

INR 10/- each

INR 0.100 Million

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in INR Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2017

31.03.2016

31.03.2015

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

0.100

0.100

0.100

(b) Reserves & Surplus

31.579

29.832

29.498

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

31.679

29.932

29.598

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) Long-term borrowings

0.000

0.000

0.000

(b) Deferred tax liabilities (Net)

0.000

0.000

0.000

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

0.960

1.142

0.110

Total Non-current Liabilities (3)

0.960

1.142

0.110

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

0.000

0.000

0.000

(b) Trade payables

23.267

13.843

11.750

(c) Other current liabilities

15.356

8.893

14.473

(d) Short-term provisions

0.014

0.502

1.860

Total Current Liabilities (4)

38.637

23.238

28.083

 

 

 

 

TOTAL

71.276

54.312

57.791

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

1.056

1.039

1.087

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Capital work-in-progress

0.000

0.000

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

0.497

0.525

0.281

(d)  Long-term Loan and Advances

4.852

3.423

3.311

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

6.405

4.987

4.679

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

10.000

20.606

27.768

(b) Inventories

13.481

9.481

10.741

(c) Trade receivables

27.491

2.187

0.158

(d) Cash and cash equivalents

1.375

2.925

1.329

(e) Short-term loans and advances

12.363

14.124

13.114

(f) Other current assets

0.161

0.002

0.002

Total Current Assets

64.871

49.325

53.112

 

 

 

 

TOTAL

71.276

54.312

57.791

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

 

SALES

 

 

 

 

 

Revenue from Operations

120.097

123.238

80.984

 

 

Other Income

8.442

7.035

7.277

 

 

TOTAL                                    

128.539

130.273

88.261

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Materials Consumed

51.663

49.359

38.773

 

 

Purchases of Stock-in-Trade

32.481

37.175

16.862

 

 

Changes in inventories

(0.768)

0.000

1.359

 

 

Employees benefits expense

13.695

11.861

10.714

 

 

Other expenses

29.079

29.880

16.639

 

 

TOTAL                                    

126.150

128.275

84.347

 

 

 

 

 

 

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

2.389

1.998

3.914

 

 

 

 

 

Less

FINANCIAL EXPENSES                       

0.194

0.165

0.118

 

 

 

 

 

 

PROFIT/ (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION              

2.195

1.833

3.796

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                    

0.399

0.406

0.616

 

 

 

 

 

 

PROFIT/ (LOSS) BEFORE TAX                        

1.796

1.427

3.180

 

 

 

 

 

Less

TAX                                                                 

0.048

1.093

0.592

 

 

 

 

 

 

PROFIT/ (LOSS) AFTER TAX               

1.748

0.334

2.588

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Traded Goods

1.535

0.837

0.000

 

TOTAL IMPORTS

1.535

0.837

0.000

 

 

 

 

 

 

Earnings/ (Loss) Per Share (INR)

174.76

33.38

258.77

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Current Maturities of Long term debt

NA

NA

NA

 

 

 

 

Cash generated from operations

(7.498)

(4.974)

(26.706)

 

 

 

 

Net Cash flow from operating activities 

(7.873)

(5.848)

(33.668)

 

 

KEY RATIOS

 

EFFICIENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Average Collection Days

(Sundry Debtors / Income * 365 Days)

83.55

6.48

0.71

 

 

 

 

Account Receivables Turnover

(Income / Sundry Debtors)

4.37

56.35

512.56

 

 

 

 

Average Payment Days

(Sundry Creditors / Purchases * 365 Days)

100.93

58.39

77.09

 

 

 

 

Inventory Turnover

(Operating Income / Inventories)

0.18

0.21

0.36

 

 

 

 

Asset Turnover

(Operating Income / Net Fixed Assets)

2.26

1.92

3.60

 

LEVERAGE RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Debt Ratio

((Borrowing + Current Liabilities) / Total Assets)

0.54

0.43

0.49

 

 

 

 

Debt Equity Ratio

(Total Liability / Networth)

0.00

0.00

0.00

 

 

 

 

Current Liabilities to Networth

(Current Liabilities / Net Worth)

1.22

0.78

0.95

 

 

 

 

Fixed Assets to Networth

(Net Fixed Assets / Networth)

0.03

0.03

0.04

 

 

 

 

Interest Coverage Ratio

(PBIT / Financial Charges)

12.31

12.11

33.23

 

PROFITABILITY RATIOS

 

PARTICULARS

 

 

31.03.2017

31.03.2016

31.03.2015

Net Profit Margin

((PAT / Sales) * 100)

%

1.46

0.27

3.20

 

 

 

 

 

Return on Total Assets

((PAT / Total Assets) * 100)

%

2.45

0.61

4.48

 

 

 

 

 

Return on Investment (ROI)

((PAT / Networth) * 100)

%

5.52

1.12

8.74

 

SOLVENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Current Ratio

(Current Assets / Current Liabilities)

1.68

2.12

1.89

 

 

 

 

Quick Ratio

((Current Assets – Inventories) / Current Liabilities)

1.33

1.71

1.51

 

 

 

 

G-Score Ratio Financial

(Networth / Total Assets)

0.44

0.55

0.51

 

 

 

 

G-Score Ratio Debt

(Debts / Equity Capital)

0.00

0.00

0.00

 

 

 

 

G-Score Ratio Liquidity

(Total Current Assets / Total Current Liabilities)

1.68

2.12

1.89

Total Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term debts

 


 

FINANCIAL ANALYSIS

[all figures are in INR Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2015

31.03.2016

31.03.2017

 

INR In Million

INR In Million

INR In Million

Share Capital

0.100

0.100

0.100

Reserves & Surplus

29.498

29.832

31.579

Money received against share warrants

0.000

0.000

0.000

Share Application money pending allotment

0.000

0.000

0.000

Net worth

29.598

29.932

31.679

 

 

 

 

long-term borrowings

0.000

0.000

0.000

Short term borrowings

0.000

0.000

0.000

Total borrowings

0.000

0.000

0.000

Debt/Equity ratio

0.000

0.000

0.000

 

 


 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2015

31.03.2016

31.03.2017

 

INR In Million

INR In Million

INR In Million

Sales

80.984

123.238

120.097

 

 

52.176

-2.549

 

 


 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2015

31.03.2016

31.03.2017

 

INR In Million

INR In Million

INR In Million

Sales

80.984

123.238

120.097

Profit/ (Loss)

2.588

0.334

1.748

 

3.20%

0.27%

1.46%

 


 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report

(Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

No

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

No

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

No

16

No. of employees

No

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

No

21

Banking facility details

No

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

No

32

Litigations that the firm/promoter involved in

--

33

Market information

--

34

Payments terms

No

35

Negative Reporting by Auditors in the Annual Report

No

 

 

INDEX OF CHARGES: NO CHARGES EXISTS FOR COMPANY

GENERAL INFORMATION

 

Subject is in the business of manufacturing and trading of pharmaceutical products and provides consultancy services.

 

OPERATIONS:

 

The company continues to be engaged in the activities pertaining to sales of drugs and pharma products.

 

There was no change in nature of the business of the company, during the year.

 

 

FIXED ASSETS:

 

·         Plant and Machinery

·         Furniture and Fixture

·         Office equipment

·         Computer

 

 

 

 

 

 

 


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

INR

US Dollar

1

INR 68.21

UK Pound

1

INR 91.43

Euro

1

INR 80.24

 

 

INFORMATION DETAILS

 

Information Gathered by :

GYT

 

 

Analysis Done by :

NYT

 

 

Report Prepared by :

RUP

 


 

SCORE FACTORS

 

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

NO

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

 

 

RATING EXPLANATIONS

 

Credit Rating

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

A+

Low Risk

Business dealings permissible with low risk of default

A

Acceptable Risk

Business dealings permissible with moderate risk of default

B

Medium Risk

Business dealings permissible on a regular monitoring basis

C

Medium High Risk

Business dealings permissible preferably on secured basis

D

High Risk

Business dealing not recommended or on secured terms only

NB

New Business

No recommendation can be done due to business in infancy stage

NT

No Trace

No recommendation can be done as the business is not traceable

 

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

 

·         Financial condition covering various ratios

·         Company background and operations size

·         Promoters / Management background

·         Payment record

·         Litigation against the subject

·         Industry scenario / competitor analysis

·         Supplier / Customer / Banker review (wherever available)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.